Zaltrap (ziv-aflibercept) Medicine

Medical Evidence

Generic name : Ziv-aflibercept.

Trade name : Zaltrap.

Manufacturer information :

Zaltrap is manufactured by Sanofi and Regeneron Pharmaceuticals, Inc.

Zaltrap FDA Approval :

Zaltrap first approved August 3rd, 2012.

Zaltrap Dosage form :

Colorectal cancer : 4 mg/kg IV.

Zaltrap Indications and Usage :

Colorectal Cancer

Indicated in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) for metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin regimen.

Zaltrap (Ziv-aflibercept) availability in India

• You could import this medicine against import permit on Patient Name.
• Please contact ACT Lifesciences Private Limited for further information.